PAREXEL Opens Clinical Logistics Facilities in Singapore and Russia
BOSTON, Dec. 6, 2010 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global biopharmaceutical services provider, today announced that it has opened two new Clinical Logistics Services facilities in emerging regions for biopharmaceutical development. PAREXEL's new depot in Singapore and ancillary warehouse in Russia will support its clients in more effectively managing their global clinical trial supply requirements. These facilities serve as an extension of PAREXEL's existing infrastructure of depots and ancillary warehouses based throughout North America, Latin America, Europe, and Africa, as well the Asia/Pacific region.
With one of the largest and most comprehensive clinical research organizations in Eastern Europe and the Asia/Pacific region, PAREXEL has further strengthened its ability to meet the Clinical Logistics Services needs of its clients through the addition of these new facilities. The new depot in Singapore handles the distribution of investigational medicinal products and non-investigational medicinal products, as well as ancillary supplies needed for clinical trials conducted by PAREXEL. The Company's new ancillary warehouse in Russia is intended to store any non-drug material required for clinical trials in Russia, including lab kits, drug application material, and medical supplies and equipment, as well as documents, such as patient diaries and questionnaires. The new facilities feature 24/7/365 monitoring systems, and provide a number of services to PAREXEL's clients including inventory management, as well as return and destruction capabilities.
"The opening of these new facilities within our global Clinical Logis